The Foundation for Managed Care Pharmacy (FMCP) is pleased to invite you to attend:

Paying for Pharmaceuticals: Performance Based Pricing and Outcomes

An Interactive Forum for the Pharmaceutical and Biotech Industries

Program Description

As increasing numbers of promising but expensive biologic agents and medical treatments are introduced into the healthcare market, how do we address the challenges faced by the current research enterprise to generate the information decision-makers need to determine the cost-effectiveness of these new technologies?  Through contracting incentives, can payers hold manufacturers responsible for how their products perform in the medical marketplace?  Payment based on results has long been touted as a way to avoid waste and increase value in health care.  The potential to apply this concept to health outcomes for pharmaceuticals is generating considerable interest on the part of payers and manufacturers.

In 2007 both the lay and trade press reported with great fanfare Johnson & Johnson’s groundbreaking proposal that Britain’s national health service pay for one of their cancer drugs, but only for patients who show a positive response to the therapy.  Meanwhile, the Centers for Medicare and Medicaid Services (CMS) has introduced a new term into the healthcare vernacular – Coverage with Evidence Development – agreeing to pay for certain products and procedures only if patients participate in studies to determine the long-term benefits/risks or are included in national patient registries.

How will payers and manufacturers overcome the difficulty in measuring outcomes?  What evidence is needed to clearly define objective measures of results?  How will this evidence be generated?  Can this model be broadly applied, if at all, in the ?  Is there potential to actually increase the use of a drug by maximizing the number of patients who respond?  But how do we address patient variability and treatment benefit variability?  How will this and other risk-sharing models evolve?

These are just some of the questions that the keynote presenters and reactor panelists will address.  FMCP will assemble an expert faculty and group of panelists from managed healthcare systems and the pharmaceutical industry to present a highly interactive forum for representatives of the pharmaceutical and biotech industries to address these issues.  Don’t miss this opportunity to interact with our faculty to address your most immediate concerns about these issues.

The seminar will be held on Tuesday, April 15, 2008 at the Moscone West Convention Center, San Francisco, California, Room 2005

WHO SHOULD ATTEND? This forum is designed primarily for representatives of pharmaceutical and biotech manufacturers and their consultants.  However, the program will be informative for managed health care system pharmacists and other health care professionals who have responsibility for development and managment of policies and procedures for the pharmacy benefit

REGISTRATION FEES:  Early Bird Rate (on or before March 18, 2008):  $375.00
                                     Full Registration (after March 18 and onsite):   $450.00
Group discounts are available for companies registering 5 or more representatives at the same time

        Online registration is Now Closed!!  Onsite Registration Will be Available.

For a printable registration form, program description and agenda: CLICK HERE.  Save time - complete this form and bring it with you our registration table.